MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Medtech in a Minute: Sterigenics Loses Big in Court, and More

Medtech in a Minute.png
Catch up on the latest medtech news – in one minute or less.

Sterigenics Loses Big in Court

Sterigenics plans to appeal a $363 million guilty verdict awarded to Willowbrook, IL resident and cancer survivor Susan Kamuda. It is the highest jury verdict on record for an individual plaintiff in the state of Illinois, and even exceeds the $346 million Kamuda's lawyers asked for in closing arguments against Sterigenics, parent company Sotera Health and its corporate predecessor Griffith Foods. Ethylene oxide (EtO) continues to be king of medical device sterilization for everything from wound dressings to stents. The reason this flammable, colorless gas is such a popular method in this industry is because for many devices, sterilization with ethylene oxide may be the only method that effectively sterilizes without damaging the device in the process. Medical devices made from certain polymers (plastic or resin), metals, or glass, or that have multiple layers of packaging or hard-to-reach places (for example, catheters), are likely to be sterilized with EtO.

Avita Medical Abruptly Replaces CEO

James "Jim" Corbett, has been tapped to lead Avita Medical as CEO. Corbett, who already served on Avita's board, replaces Michael Perry, effective immediately. The transition comes at a time when Avita's shares are at their lowest level in years. Perry had served as Avita's CEO since June 2017. The Cambridge, UK-based company touts Corbett's nearly 40 years of experience in the life sciences field, and that he has served as CEO of multiple publicly traded companies, including Microtherapeutics, Ev3, and Alphatec Spine. He also served as CEO at Home Diagnostics, Vertos Medical, and CathWorks.

And in case you missed our last Medtech in a Minute report...

It's a Swing and a Miss for Boston Scientific's Cerebral Protection Device

Boston Scientific failed to meet the primary endpoint of reduced stroke in the PROTECTED TAVR study. The company presented the results of the study, which evaluated the Sentinel Cerebral Protection system, last weekend at the Transcatheter Cardiovascular Therapeutics (TCT) annual scientific symposium in Boston. The device was designed to capture and remove embolic debris stemming from transcatheter aortic valve replacement before it can reach the brain and potentially cause a stroke.

Medtronic Uncovers Cybersecurity Problem with MiniMed 600 Insulin Pump

Medtronic issued an urgent medical device correction warning of a MiniMed 600 Series insulin pump system communication issue uncovered by the company. Medtronic reported in its September 20 letter that these insulin pump systems are vulnerable to cyberattacks and hackers could potentially hamper insulin delivery by accessing the device, administering too much or too little insulin to the devices recipient.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.